# Kenvue Inc.: overview

KVUE · NYSE · CIK 1944048 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/kvue.md) · [Financials](/companies/kvue/financials.md) · [Filings](/companies/kvue/filings.md) · [Insiders](/companies/kvue/insiders.md)

Latest reported revenue: [$3.96bn](/filings/0001944048-26-000142.md) for Q2 FY2026, three months to 2026-06-28, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001944048-26-000142).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,899](/filings/0001944048-25-000198.md) | [3,662 d](/filings/0001944048-26-000030.md) | [3,741](/filings/0001944048-26-000098.md) | [3,839](/filings/0001944048-26-000142.md) | [3,764](/filings/0001944048-25-000198.md) | [3,780 d](/filings/0001944048-26-000030.md) | [3,909](/filings/0001944048-26-000098.md) | [3,955](/filings/0001944048-26-000142.md) |
| Gross margin | % | [58.5%](/filings/0001944048-25-000198.md) | [56.5% d](/filings/0001944048-26-000030.md) | [58.0%](/filings/0001944048-26-000098.md) | [58.9%](/filings/0001944048-26-000142.md) | [59.1%](/filings/0001944048-25-000198.md) | [56.5% d](/filings/0001944048-26-000030.md) | [58.9%](/filings/0001944048-26-000098.md) | [58.2%](/filings/0001944048-26-000142.md) |
| Operating margin | % | [16.8%](/filings/0001944048-25-000198.md) | [13.2% d](/filings/0001944048-26-000030.md) | [14.9%](/filings/0001944048-26-000098.md) | [18.0%](/filings/0001944048-26-000142.md) | [16.7%](/filings/0001944048-25-000198.md) | [14.2% d](/filings/0001944048-26-000030.md) | [19.6%](/filings/0001944048-26-000098.md) | [17.7%](/filings/0001944048-26-000142.md) |
| Net margin | % | [9.8%](/filings/0001944048-25-000198.md) | [8.0% d](/filings/0001944048-26-000030.md) | [8.6%](/filings/0001944048-26-000098.md) | [10.9%](/filings/0001944048-26-000142.md) | [10.6%](/filings/0001944048-25-000198.md) | [8.7% d](/filings/0001944048-26-000030.md) | [12.1%](/filings/0001944048-26-000098.md) | [11.5%](/filings/0001944048-26-000142.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001944048-25-000198.md) | not reported | [0.17](/filings/0001944048-26-000098.md) | [0.22](/filings/0001944048-26-000142.md) | [0.21](/filings/0001944048-25-000198.md) | not reported | [0.25](/filings/0001944048-26-000098.md) | [0.24](/filings/0001944048-26-000142.md) |
| Free cash flow | $m | [190 d](/filings/0001944048-25-000198.md) | [661 d](/filings/0001944048-26-000030.md) | [249](/filings/0001944048-26-000098.md) | [533 d](/filings/0001944048-26-000142.md) | [196 d](/filings/0001944048-25-000198.md) | [744 d](/filings/0001944048-26-000030.md) | [350](/filings/0001944048-26-000098.md) | [624 d](/filings/0001944048-26-000142.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-01-02) | FY (2023-01-01) | FY2023 (2023-12-31) | FY2024 (2024-12-29) | FY2025 (2025-12-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [15.1](/filings/0001944048-24-000057.md) | [15.0](/filings/0001944048-25-000033.md) | [15.4](/filings/0001944048-26-000030.md) | [15.5](/filings/0001944048-26-000030.md) | [15.1](/filings/0001944048-26-000030.md) |
| Gross margin | % | [55.9%](/filings/0001944048-24-000057.md) | [55.4%](/filings/0001944048-25-000033.md) | [56.0%](/filings/0001944048-26-000030.md) | [58.0%](/filings/0001944048-26-000030.md) | [58.1%](/filings/0001944048-26-000030.md) |
| Operating margin | % | [19.4%](/filings/0001944048-24-000057.md) | [17.9%](/filings/0001944048-25-000033.md) | [16.3%](/filings/0001944048-26-000030.md) | [11.9%](/filings/0001944048-26-000030.md) | [16.0%](/filings/0001944048-26-000030.md) |
| Net margin | % | [13.8%](/filings/0001944048-24-000057.md) | [13.8%](/filings/0001944048-25-000033.md) | [10.8%](/filings/0001944048-26-000030.md) | [6.7%](/filings/0001944048-26-000030.md) | [9.7%](/filings/0001944048-26-000030.md) |
| Diluted EPS | $ per share | [1.21](/filings/0001944048-24-000057.md) | [1.20](/filings/0001944048-25-000033.md) | [0.90](/filings/0001944048-26-000030.md) | [0.54](/filings/0001944048-26-000030.md) | [0.76](/filings/0001944048-26-000030.md) |
| Free cash flow | $bn | [0.0](/filings/0001944048-24-000057.md) | [2.2](/filings/0001944048-25-000033.md) | [2.7](/filings/0001944048-26-000030.md) | [1.3](/filings/0001944048-26-000030.md) | [1.7](/filings/0001944048-26-000030.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/kvue/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.00bn | 157,051,418 |  | Added +21,958,324 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.88bn | 150,825,694 |  | Added +5,528,402 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.39bn | 125,314,564 |  | Added +890,527 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.32bn | 121,619,054 |  | Added +2,047,808 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.78bn | 93,303,762 |  | Added +839,374 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $990.2m | 52,021,320 |  | Added +751,104 |
| [Pentwater Capital Management LP](/funds/1425851.md) | 2026-06-30 | $977.1m | 51,130,000 |  | Reduced −870,000 |
| [Independent Franchise Partners LLP](/funds/1483866.md) | 2026-06-30 | $963.7m | 50,427,994 |  | Added +1,219,146 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $882.1m | 46,156,826 |  | New +46,156,826 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $861.9m | 44,715,586 |  | Reduced −5,028,398 |

## Recent filings

[All 454 filings](/companies/kvue/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 11:26 ET | [8-K](/filings/0000950157-26-001094.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950157-26-001094 |
| 2026-08-06 | 11:01 ET | [10-Q](/filings/0001944048-26-000142.md) | Quarterly report, period 2026-06-28 | 0001944048-26-000142 |
| 2026-08-06 | 10:48 ET | [8-K](/filings/0001944048-26-000141.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001944048-26-000141 |
| 2026-05-22 | 20:57 ET | [8-K](/filings/0001944048-26-000102.md) | 5.07 Shareholder vote results | 0001944048-26-000102 |
| 2026-05-07 | 11:50 ET | [10-Q](/filings/0001944048-26-000098.md) | Quarterly report, period 2026-03-29 | 0001944048-26-000098 |
| 2026-05-07 | 10:32 ET | [8-K](/filings/0001944048-26-000097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001944048-26-000097 |
| 2026-04-15 | 13:06 ET | [8-K](/filings/0000950157-26-000493.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950157-26-000493 |
| 2026-04-08 | 20:19 ET | [DEF 14A](/filings/0001944048-26-000085.md) | Proxy statement, period 2025-12-28 | 0001944048-26-000085 |
| 2026-02-20 | 12:13 ET | [10-K](/filings/0001944048-26-000030.md) | Annual report, period 2025-12-28 | 0001944048-26-000030 |
| 2026-02-17 | 21:46 ET | [8-K](/filings/0001944048-26-000016.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001944048-26-000016 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 28, 2025](/filings/0001944048-26-000030.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-28, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/df6f320b-98cc-48ef-b51b-5daef8e2a1a4)

## About the filer

- CIK: 1944048
- Tickers: KVUE
- Exchange: NYSE
- SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.